Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasis
about
Leishmania RNA virus: when the host pays the tollChallenges in the therapy of visceral leishmaniasis in Brazil: a public health perspective.The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana.
P2860
Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasis
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@ast
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@en
type
label
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@ast
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@en
prefLabel
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@ast
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@en
P2093
P2860
P356
P1476
Enhancement of a TH1 immune re ...... ed mucocutaneous leishmaniasis
@en
P2093
Celeste Rodríguez
Ingrid Guachalla
Janeth Riva
Rianed Velasquez
Washington R Cuna
P2860
P356
10.1155/2007/96410
P577
2007-01-01T00:00:00Z